Indo National has scheduled its 53rd Annual General Meeting for September 28, 2026, proposing a dividend of ₹3.75 per equity share for FY26. The payout represents 75% of the ₹5 face value and is set against a backdrop of declining profitability.

The company reported a pre-tax loss of ₹996.71 lakh for the year ended March 31, 2026, reversing a profit of ₹106.39 lakh recorded in FY25. Management attributed the deterioration to steep increases in raw material costs, a shift in sales volume mix, and the conversion of battery-operated torches to rechargeable models.

Financial Performance

Despite the operational loss, the company’s net worth stood at ₹21,210.24 lakh as on March 31, 2026, supporting a book value per share of ₹282.80. The board indicated that adequate steps have been taken to recover profits, citing considerable demand recovery in Q1FY27.

What the Numbers Show

The declaration of a dividend yielding 75% of face value amidst a significant pre-tax loss highlights a reliance on retained earnings or cash reserves rather than current period profitability. With net worth remaining robust at over ₹2,100 crore, the payout does not immediately threaten solvency, but it underscores a divergence between operational performance and shareholder returns.

Corporate Governance Updates

Shareholders will vote on the re-appointment of Ms. Suneeta Reddy as a Non-Executive Director. She retires by rotation and offers herself for re-appointment. Ms. Reddy holds 119,160 shares in the company and brings 31 years of experience, primarily in healthcare services.

The meeting will also seek approval for:

• Remuneration of ₹1,00,000 plus out-of-pocket expenses to M/s. B. Thulasiram & Co. as Cost Auditor for FY27.
• Payment of profit-related commission to Non-Executive Independent Directors for FY26 through FY28, capped at 1% of net profits or ₹5,00,000, whichever is higher.

The AGM will be conducted via Video Conferencing. Remote e-voting through CDSL will be open from September 25 to September 27, 2026. The register of members will remain closed from September 22 to September 28, 2026.

Indo National acquired an additional 0.78% equity stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹50,03,864 on September 2, 2026. The transaction increases the company’s total shareholding in the air monitoring systems firm to 61.87%.

The investment was made through a cash subscription to equity shares, based on valuation reports issued by a registered valuer. The acquisition is not classified as a related-party transaction, and no promoters or group companies hold an interest in MMSPL.

Transaction Details

Indo National purchased 329 equity shares in two tranches during 2026:

• 153 shares at ₹16,536 per share, based on a valuation report dated May 16, 2026.
• 176 shares at ₹14,056 per share, based on a valuation report dated August 21, 2026.

The company disclosed the move under Regulation 30 of the SEBI LODR regulations. No governmental or regulatory approvals were required for the acquisition.

Target Entity Profile

Medcuore Medical Solutions Private Ltd is engaged in the manufacturing, distribution, and servicing of air monitoring systems and air purifiers. Incorporated on June 7, 2020, the entity operates exclusively in India.

MMSPL’s turnover rose significantly in FY26 compared to FY25, following a dip in FY24. The company stated that the acquisition aims to facilitate business growth and generate revenue through expansion.

What the Numbers Show

The divergence in per-share pricing between the May and August tranches indicates a lower valuation basis for the later purchase. The August tranche price of ₹14,056 was approximately 15% lower than the May price of ₹16,536, suggesting a adjustment in the target’s valuation metrics between the two reporting dates.